A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanced cancers
64619178EDI1001
Phase 1 other active
Quick answer
A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanced cancers for Previously treated lymphoma (blood cancer) or solid tumors and NHL is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Previously treated lymphoma (blood cancer) or solid tumors and NHL
- Phase
- Phase 1
- Modality
- other
- Status
- active